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Abstract
The lipid binding behaviour of the antimicrobial peptides magainin 1, melittin and the C-terminally truncated analogue of
melittin (21Q) was studied with a hybrid bilayer membrane system using surface plasmon resonance. In particular, the
hydrophobic association chip was used which is composed of long chain alkanethiol molecules upon which liposomes adsorb
spontaneously to create a hybrid bilayer membrane surface. Multiple sets of sensorgrams with different peptide
concentrations were generated. Linearisation analysis and curve fitting using numerical integration analysis were performed
to derive estimates for the association (ka) and dissociation (kd) rate constants. The results demonstrated that magainin 1
preferentially interacted with negatively charged dimyristoyl-L-K-phosphatidyl-DL-glycerol (DMPG), while melittin
interacted with both zwitterionic dimyristoyl-L-K-phosphatidylcholine and anionic DMPG. In contrast, the C-terminally
truncated melittin analogue, 21Q, exhibited lower binding affinity for both lipids, showing that the positively charged C-
terminus of melittin greatly influences its membrane binding properties. Furthermore the results also demonstrated that these
antimicrobial peptides bind to the lipids initially via electrostatic interactions which then enhances the subsequent
hydrophobic binding. The biosensor results were correlated with the conformation of the peptides determined by circular
dichroism analysis, which indicated that high K-helicity was associated with high binding affinity. Overall, the results
demonstrated that biosensor technology provides a new experimental approach to the study of peptide-membrane
interactions through the rapid determination of the binding affinity of bioactive peptides for phospholipids. ß 2001
Elsevier Science B.V. All rights reserved.
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1. Introduction
Interactions between bioactive peptides and cell
membranes play a key role in a number of cellular
processes, including the insertion and folding of
membrane proteins, the formation and structure of
ion channels, the interaction of hormones with mem-
brane receptors and the action of antimicrobial and
cytotoxic peptides. The common structural feature of
all these classes of molecules is the adoption of a
stable secondary structure upon binding to the mem-
brane surface. In the case of antimicrobial peptides,
0005-2736 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 1 ) 0 0 3 0 3 - 0
* Corresponding author. Fax: +61-3-9905-5882;
E-mail : mibel.aguilar@med.monash.edu.au
BBAMEM 78077 17-4-01
Biochimica et Biophysica Acta 1512 (2001) 64^76
www.bba-direct.com
such as magainin [1,2], melittin [2,3] and cecropin [4],
which act by perturbing the barrier function of the
cell membrane [5,6], the induction of cationic, am-
phipathic K-helical structure is thought to play an
essential role in their biological activity.
There have been several studies largely using mod-
el membrane systems [7,8] aimed at characterising
the mechanism of membrane permeabilisation by
antimicrobial peptides. A number of physicochemical
properties, such as peptide charge, hydrophobicity,
amphipathicity and the degree of secondary structure
angle subtended by the polar face, have all been
shown to play a role in the cell-lytic properties of
these peptides. However, since selective binding to
di¡erent phospholipids is central to the design of
non-haemolytic antimicrobial peptides, the a⁄nity
of the peptide for the membrane surface is also a
critical factor in the cell-lytic process, but is not com-
monly measured and reported. This is largely due to
the di⁄culty in generating these data, since mem-
brane binding assays generally require a physical sep-
aration step, such as dialysis or centrifugation which
can be tedious for large numbers of samples [9,10].
Alternatively, peptide partitioning can be directly
measured by changes in £uorescence quenching or
enhancement of tryptophan £uorescence which relies
on the presence of a £uoroprobe. If an intrinsic £uo-
roprobe is not present, the probe must be incorpo-
rated by covalent modi¢cation of the peptide and/or
the lipid [11,12].
We have developed a new and sensitive method
based on surface plasmon resonance (SPR), which
allows the real-time measurement of peptide binding
to phospholipid membranes. In the present study, the
lipid binding characteristics, in terms of their relative
a⁄nity, of two antimicrobial peptides magainin 1,
melittin and a truncated analogue of melittin (21Q)
with a hybrid bilayer membrane (HBM) system of
di¡erent surface charge have been studied. Small uni-
lamellar vesicles were adsorbed onto the surface of a
hydrophobic association (HPA) chip to form a hy-
brid lipid bilayer that is similar to the surface of a
cellular membrane. The binding of antimicrobial
peptides to this surface and the resulting data allow
the analysis of peptide-lipid interactions and provide
a basis to calculate rate constants associated with the
interactions. The results demonstrate that biosensor
technology has the ability to provide insight into the
relationship between the structure of a peptide and
its biological activity and membrane selectivity
through the lipid binding a⁄nity data.
2. Materials and methods
2.1. Chemicals and reagents
N-Octyl L-D-glucopyranoside, dimyristoyl-L-K-
phosphatidylcholine (DMPC), dimyristoyl-L-K-phos-
phatidyl-DL-glycerol (DMPG) and the negative con-
trol, bovine serum albumin (BSA), were purchased
from Sigma (St Louis, MO, USA). Cytolytic pep-
tides, melittin and magainin 1 were purchased from
Auspep (Parkville, Vic., Australia). The truncated
analogue of melittin (21Q) was synthesised by solid
phase peptide synthesis, puri¢ed by reversed phase
high performance liquid chromatography (RP-
HPLC) and characterised by amino acid analysis
and matrix-assisted laser desorption mass spectrom-
etry as previously described [13]. Water was quartz-
distilled and deionised in a Milli-Q system (Millipore,
Bedford, MA, USA).
2.2. Biosensor study
Biosensor experiments were carried out with a
BIAcore X analytical system (Biacore, Uppsala, Swe-
den) using an HPA sensor chip (Biacore). The HPA
sensor chip is composed of long chain alkanethiol
molecules covalently linked to the gold surface to
form a hydrophobic monolayer. The running bu¡er
used for all experiments was phosphate bu¡er (0.02
M NaH2PO4/Na2HPO4, pH 6.8). The washing solu-
tion was N-octyl L-D-glucopyranoside (40 mM). The
regeneration solution was sodium hydroxide (10
mM). All solutions were freshly prepared, degassed
and ¢ltered through a 0.22 Wm ¢lter. The operating
temperature was 25‡C. The sequence and molecular
mass of all peptides used are listed in Table 1.
2.2.1. Liposome preparation
Small unilamellar vesicles (SUV; 50 nm) of DMPC
or DMPG were prepared in 0.02 M phosphate bu¡er
by sonication. Brie£y, dry DMPC was dissolved in
ethanol-free chloroform or in the case of DMPG the
dry lipid was dissolved in a CHCl3/MeOH mixture
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(2:1, v/v). In both cases the solvent was evaporated
under a stream of nitrogen, and the lipids were held
under vacuum overnight. The lipids were then resus-
pended in 0.02 M phosphate bu¡er, via vortex mix-
ing. The resultant lipid dispersion (a concentration of
0.5 mM with respect to phospholipid) was then so-
nicated in a bath type sonicator until clear.
2.2.2. Formation of hybrid bilayer membranes
(HBM)
After cleaning as outlined in the instrument man-
ual, the BIAcore X instrument was left running over-
night using Milli-Q water as eluent to thoroughly
wash all liquid handling parts of the instrument.
The HPS sensor chip was then installed and the al-
kanethiol surface was cleaned by an injection of the
non-ionic detergent 40 mM octyl glucoside (25 Wl), at
a £ow rate of 5 Wl/min. SUV (30 Wl, 0.5 mM) were
then immediately applied to the chip surface at a low
£ow rate (2 Wl/min). To remove any multilamellar
structures from the lipid surface, sodium hydroxide
(30 Wl, 10 mM) was injected at a £ow rate of 50 Wl/
min which resulted in a stable baseline corresponding
to the HBM as previously shown [14]. The negative
control BSA was injected (10 Wl, 0.1 mg/ml in phos-
phate bu¡er) to con¢rm the complete coverage of the
chip surface with lipid by the absence of non-speci¢c
binding. This HBM was then used as a model cell
membrane surface to study the antimicrobial pep-
tide-membrane binding.
2.2.3. Antimicrobial peptide binding to HBM system
Peptide solutions were prepared by dissolving
magainin 1, melittin, and 21Q in phosphate bu¡er
from 10 to 140 WM. The solutions (80 Wl, 980 s)
were injected over the lipid surface at a £ow rate
of 5 Wl/min. The peptide solution was then replaced
by phosphate bu¡er and the peptide-HBM complex
allowed to dissociate for 1200 s. Since the peptides
interact with the HBM through hydrophobic inter-
actions, the regeneration of the HBM surface by re-
moval of the bound peptide was not possible without
also removing the phospholipid monolayer. The
phospholipid monolayer was therefore completely re-
moved with an injection of octyl glucoside and each
peptide injection was performed on a freshly gener-
ated HBM surface. All binding experiments were car-
ried out at 25‡C. The a⁄nity of the antimicrobial
peptide-lipid monolayer binding event was deter-
mined from analysis of a series of response curves
in each case, where the resultant sensorgrams were
collected at ten di¡erent peptide concentrations in-
jected over each lipid surface for each peptide. The
peptide concentrations ranged from 50 WM to 140
WM for DMPC and from 10 WM to 100 WM for
DMPG.
2.3. Circular dichroism (CD) measurements
CD measurements were carried out on a Jasco J-
810 Circular Dichroism Spectropolarimeter (Jasco,
Tokyo, Japan) between 190 and 250 nm using quartz
cells of 0.1 cm path length at 25‡C. The scan speed
was 20 nm/min and the bandwidth 1.0 nm. The res-
olution was 0.1 nm with 1 s response. The cell tem-
perature was stabilised using a peltier temperature
controller. The CD instrument was calibrated with
(+)-10-camphorsulphonic acid. The DMPC and
DMPG liposomes were prepared as described above.
The concentration of the lipid solutions was 2 mM.
CD spectra of magainin 1, melittin and 21Q were
measured in 0.02 M phosphate bu¡er (pH 6.8) and
in the presence of DMPC or DMPG vesicles at a
peptide concentration of 20 WM. Peptide concentra-
tions were determined using an HP 845U UV-visible
ChemStation spectrophotometer at 280 nm in phos-
phate bu¡er, and an extinction coe⁄cient for melittin
and 21Q of O280 = 5570 m31 cm31 was used [15]. The
Table 1
Sequence and molecular weights of bioactive peptides
Peptide Sequence MW Chargea
Melittin H2N-GIGAVLKVLTTGLPALISWIKRKRQQ-CONH2 2 847 6+
21Q H2N-GIGAVLKVLTTGLPALISWIQ-CONH2 2 150 2+
Magainin 1 H2N-GIGKPLHSAGKPGKAPVGEIMKS-COOH 2 410 4+
aTotal net charge based on the number of positively and negatively charged amino acids.
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concentration of magainin was determined by amino
acid analysis. The peptide to lipid ratio was 1:100. In
all measurements CD spectra of the same bu¡er and/
or liposome solutions without peptides were applied
as baseline. To obtain ¢nal CD spectra, the average
of a series of ¢ve CD scans was accumulated for each
sample. If required, spectra were smoothed using the
Jasco Fast Fourier Transform algorithm. The helicity
of each peptide was determined from the mean resi-
due ellipticity at 222 nm ([a]222, degcm2/dmol) ac-
cording to the relation [K] = 100U[a]222/af and
af =339 500U(132.57/n) where [K] is the amount
of helix, n is the residue number in the peptide and
af is the mean residue ellipticity of a helix of in¢nite
residues [16].
2.4. Theoretical considerations
Fig. 1 shows the con¢guration of the SPR detec-
tor, sensor chip and £ow channel in the BIAcore
system. In the BIAcore X analytical system that
uses SPR, the peptide (analyte, A) is in solution
while the lipids (ligand, B) are immobilised on the
biosensor surface forming a HBM system. In the
present study the HBM system forms one wall of a
micro£ow cell and the bu¡ered solution of peptide is
injected over the surface at a constant £ow rate. As
the peptide binds to the HBM, the instrument con-
tinuously monitors and measures the changes in the
refractive index, given in resonance units (RU), at
the surface of the HPA sensor chip to generate sen-
sorgrams as shown in Fig. 2 [17^19]. During the
binding process, the association (ka) and dissociation
(kd) rate constants control the formation and break-
down of the complex (AB) at the sensor surface, as
shown in Eq. 1.
A BIka
kd
AB 1
Using the resultant sensorgrams of each peptide,
linearisation analysis using Excel 8.0 software (Mi-
crosoft, Redmond, WA, USA) and curve ¢tting with
numerical integration using BIAevaluation 3.0 soft-
ware (Biacore) were performed to derive estimates
for kinetic constants including the association (ka)
and dissociation (kd) rate constants.
2.4.1. Linearisation analysis
The sensorgrams resulting from the peptide-lipid
interactions were analysed by linearisation analysis
[18,19]. This method involves a simple linear trans-
Fig. 1. The con¢guration of the SPR detector, sensor chip and
£ow channel in the BIAcore system. Real-time bimolecular in-
teraction analysis (BIA) that uses SPR was used to monitor the
interactions between the bioactive peptides and the membrane
system. 1, light source; 2, polarised light; 3, opto interface; 4,
re£ected light; 5, detector array; 6, prism; 7, sensor chip HPA;
8, HBM; 9, £ow cell.
Fig. 2. Monitoring the lipid monolayer formation on the HPA sensor chip surface and peptide binding onto the HBM. A, cleaning
the sensor chip surface by octyl glucoside; B, SUV deposition onto the HPA surface; C, removal of multilayers by NaOH; D, peptide
injection over the HBM; E, adsorption of the peptide; F, dissociation of the peptide; G, regeneration of the surface.
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formation of binding data to determine binding pa-
rameters. The limitation of this method is that it is
only suitable for interpreting reactions that follow a
simple bimolecular mechanism. The possible inter-
pretation of the binding reaction that this analysis
suggests, is that the peptide (P) simply binds to lipids
(L) and/or inserts into the HBM with no other inter-
actions involved as follows:
P LIPL 2
The corresponding di¡erential rate equation for this
reaction model is :
dR=dt  kaUCPURmax3kaUCP  kdUR 3
where ka and kd are the association and dissociation
rate constants respectively, Rmax is the maximum sig-
nal which is proportional to the initial concentration
of L, [CP] is the peptide concentration and R is the
signal from the biosensor which is proportional to
the amount of complex (PL).
To determine whether the peptide-lipid interac-
tions can be described by a simple 1:1 bimolecular
reaction, the association phase of the sensorgram of
the particular peptide at all peptide concentrations
was plotted against the response (dR/dt versus R).
In the case of a simple bimolecular interaction the
association rate (ka) of each peptide can be easily
determined from the slope of the dR/dt versus R
curves against peptide concentration according to
Eq. 3. The dissociation rate of each peptide can
also be determined by linearising the dissociation
phase of the highest concentration of the particular
peptide by plotting ln(R0/R) versus time (s). A linear
slope should also be observed in the case of a simple
bimolecular interaction and the slope can be used to
calculate the dissociation rate (kd) constant. R0 is the
response at the start of the dissociation phase and R
is the response at time t. However, non-linear slopes
re£ect complex interactions and the rate constants
cannot be accurately determined [19].
2.4.2. Numerical integration analysis
The sensorgrams for each peptide-lipid interaction
were also analysed by curve ¢tting using numerical
integration analysis [19,20]. The BIAevaluation soft-
ware o¡ers seven di¡erent reaction models to per-
form complete kinetic analyses of the peptide sensor-
grams. Three di¡erent curve ¢tting algorithms were
chosen for comparison, on the basis of what is
known about the possible binding mechanisms of
antimicrobial peptides. In order to distinguish be-
tween the possible binding models, the data were
¢tted globally by simultaneously ¢tting the peptide
sensorgrams obtained at ten di¡erent concentrations.
To improve the ¢t, the sensorgrams at each peptide
concentration were ¢tted separately, i.e. non-glob-
ally.
First, each peptide-lipid system was analysed using
the simple Langmuir binding, one-to-one reaction
model. The binding mechanism described by this
model is that the peptide (P) binds to lipids (L)
and/or inserts into the HBM, as described in Section
2.4.1.
The two-state reaction model was also applied to
each data set. This model describes two reaction
steps which, in terms of peptide-lipid interaction,
may correspond to:
P LIPLIPL 4
where: (1) Peptide (P) binds to lipids (L) to give PL.
(2) The complex PL changes to PL* which cannot
dissociate directly to P+L and which may correspond
to partial insertion of the peptide into the HBM. The
corresponding di¡erential rate equations for this re-
action model are represented by:
dR1=dt  ka1UCAURmax3R13R23
kd1UR13ka2UR1  kd2UR2 5
dR2=dt  ka2UR13kd2UR2 6
The parallel reactions model was also applied to
each data set. This model assumes that two simple
bimolecular interactions occur in parallel with di¡er-
ent rate constants giving a complex bimolecular in-
teraction as follows.
1. Peptide (P) binds to lipids (L).
P LIPL 7
2. The bound peptide (P*) then provides a surface
for the binding of additional peptide molecules,
e.g. possible pore formation (T).
P  TIPT 8
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The corresponding di¡erential rate equations for this
reaction model are:
dR1=dt  ka1UCpURmax3R13R1Ukd1
9
dR2=dt  ka2UCpURmax3R23R2Ukd2
10
3. Results
3.1. Biosensor study
In the present study the lipid binding properties of
three bioactive peptides, magainin 1, melittin and the
C-terminally truncated analogue of melittin (21Q),
were investigated in the presence of zwitterionic or
anionic lipid surfaces using real time, label free bio-
sensor technology. To investigate the di¡erent mem-
brane selectivity and binding a⁄nity of these pep-
tides, HBM systems composed of either zwitterionic
(DMPC) or anionic (DMPG) lipids were used. Fig. 3
schematically shows the proposed stepwise formation
of the supported lipid monolayer on the alkanethiol
surface of the HPA sensor chip. The ¢gure illustrates
that the SUV adsorb spontaneously to form a sup-
ported lipid monolayer on the hydrophobic alkane-
thiol surface, providing a model cell membrane sur-
face. Phosphate bu¡ered solutions of each peptide
were passed over the HBM surface at a constant
£ow rate. A typical sensorgram obtained for the pro-
Fig. 3. Preparation of the HBM system. (A) The HPA chip is
composed of long chain alkanethiol molecules covalently linked
to the gold surface to form a £at hydrophobic alkanethiol sur-
face. (B) SUV (50 nm) are applied to the sensor chip surface.
(C) Liposomes adsorb to the surface spontaneously and (D)
form a supported lipid monolayer.
Fig. 4. Comparative peptide sensorgrams for (A) melittin (90
WM), (B) magainin 1 (90 WM) and (C) 21Q (80 WM) on DMPC
(solid lines) and DMPG (dashed lines).
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cess of lipid deposition, lipid monolayer formation
on the HPA sensor chip and the binding of a peptide
into the prepared lipid monolayer is shown in Fig. 2.
The detected association rate of the peptides did not
vary notably when the £ow rate was varied from 1 to
10 Wl/min, indicating that the interaction was not
mass transport limited (data not shown).
Fig. 4 shows the comparative sensorgrams ob-
tained for each peptide with both lipids. Initial in-
spection of the shape of each sensorgram reveals dif-
ferent binding kinetics with signi¢cant di¡erences in
both association and dissociation rates for both lipid
surfaces. In particular, the sensorgrams indicate that
the peptides bind to the lipid surfaces in a biphasic
manner. The initial association of the peptide to the
lipid surface starts as a very fast process, which then
slows down considerably towards the end of the pep-
tide injection and does not reach equilibrium. The
dissociation of the HBM bound complex follows a
similar pattern, with the signal falling rapidly at the
end of injection since the peptide is no longer present
and the bu¡er £ow removes a large amount of free
or weakly bound peptide, followed by a much slower
step. Typically, the peptide sensorgrams did not re-
turn to zero, indicating that a proportion of the pep-
tide remained bound to the surface or inserted into
the HBM. This was observed for almost all peptide-
lipid combinations with the exception of 21Q with
DMPG.
Di¡erent responses, measured in RU, were ob-
tained with the di¡erently charged lipid surfaces di-
rectly indicating that a higher proportion of magai-
nin 1 and melittin bound to the anionic DMPG than
to zwitterionic DMPC and that a higher proportion
of melittin bound to both lipids than the truncated
21Q analogue. In addition, the shape of the sensor-
grams also re£ects that melittin bound more rapidly
than 21Q to both lipids. In contrast, similarly shaped
sensorgrams were obtained for 21Q on DMPC and
DMPG, which indicates similar kinetics of 21Q for
both lipids. Using the peptide sensorgrams, linearisa-
tion analysis and curve ¢tting with numerical inte-
gration were then performed to derive estimates for
the association (ka) and dissociation (kd) rate con-
stants and the binding a⁄nity of the peptide-lipid
interactions.
3.1.1. Linearisation
The linearisation method is widely used to estimate
the rate constants for interactions that follow a sim-
ple bimolecular mechanism or Langmuir interaction
(see Eq. 1) [18,19]. Using this method the possibility
of a simple bimolecular interaction was eliminated by
linearising the association phase data of the sensor-
grams and the dissociation phase data of the highest
concentration peptide sensorgram as described in
Section 2.4. Fig. 5A,B show the linearisation of the
association phase and dissociation phase data for the
binding of melittin to DMPC. It is evident from this
¢gure that curved plots were obtained at all peptide
concentrations, and similar data were observed for
melittin with DMPG and 21Q and magainin 1 on
both DMPC and DMPG. Since the plots should ap-
pear linear for a simple bimolecular interaction, the
results indicate that the peptide-lipid binding reac-
tions are more complex than can be described by a
simple 1:1 interaction. Alternative methods were
then used to derive thermodynamic constants.
3.1.2. Numerical integration analysis
Numerical integration analysis that uses non-linear
analysis to ¢t an integrated rate equation directly to
the sensorgrams was employed. Fitting the peptide
sensorgrams both globally and non-globally, a poor
¢t was obtained using the simplest 1:1 Langmuir
binding model (data not shown), con¢rming that
this model does not represent the lipid binding mech-
Fig. 5. Analysis by linearisation for the binding of melittin to
DMPC. The linearisation of (A) association and (B) dissocia-
tion phase data resulted in curved plots, re£ecting a complex
bimolecular interaction for each peptide.
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anism of antimicrobial peptides. However, signi¢-
cantly improved ¢t was obtained using numerical
integration of the two-state reaction model and the
parallel reactions model on the binding sensorgrams.
Fig. 6A,B show the ¢tted sensorgrams obtained
using the two-state reaction system and the parallel
reactions system, respectively. The ¢gures also show
the component signals associated with the two bound
forms of the peptide PL and PL* or PT and P*L,
which make up the output response. For the two-
state reaction and the parallel reactions models, the
¢rst step is most likely to be the initial binding of the
peptide to the membrane surface to give either PL or
P*L. The second steps are then either insertion of the
peptide into the membrane interior (PL*) and/or
subsequent binding of additional peptide to initiate
pore formation (PT). The relative rate constants for
each of these states will determine which model is
most appropriate for these peptide-membrane inter-
actions.
Kinetic analysis of the interactions was carried out
using these two models. A set of peptide sensorgrams
with ten di¡erent analyte concentrations was used to
estimate the kinetic parameters. The average values
for the rate constants obtained from the analysis are
listed in Table 2 and 3 along with the association
constant values (KA, KA1 and KA2) for both systems.
The association constants were calculated from the
association and dissociation rate constants estab-
lished by both reaction models for the di¡erently
surface charged HBM systems. The two-state reac-
tion model supplies a single KA value while the par-
allel reactions model provides two KA values, KA1
and KA2. It is possible that KA1 describes the initial
binding of the peptide to the membrane, and KA2
relates to the subsequent peptide-peptide interaction.
This phenomenon has also been recently observed
for the binding of model amphipathic peptides to
mixed liposomes containing phosphatidylcholine/
phosphatidylglycerol/phosphatidylethanolamine [21].
The association constants determined by the two-
state reaction model, listed in Table 2, demonstrated
that magainin 1 and melittin had a much higher
binding a⁄nity for the anionic DMPG than for the
zwitterionic DMPC. Melittin also displayed a much
higher binding a⁄nity for both lipids than magainin
1. This is consistent with previous studies, which
showed that both peptides bind more strongly to
negatively charged liposomes than zwitterionic lipo-
somes [7,22^24]. In particular, the magnitudes of KA
values obtained are similar to those previously re-
Fig. 6. Analysis by numerical integration for the binding of me-
littin to DMPC. Fitted sensorgrams obtained using (A) the
two-state reaction system and (B) the parallel reactions system.
Table 2
Association (ka1, ka2) and dissociation (kd1, kd2) rate constants determined by numerical integration using the two-state reaction mod-
el, and the a⁄nity constant (K) determined as (ka1/kd1)U(ka2/kd2)
Peptide Lipid type ka1 (1/Ms) kd1 (1/s) ka2 (1/Ms) kd2 (1/s) K (1/M)
Melittin DMPC 209 134U1034 8.0U1034 3.8U1034 3.3U104
DMPG 1 671 41U1034 3.5U1034 0.7U1034 206U104
21Q DMPC 51 62U1034 9.7U1034 3.5U1034 2.3U104
DMPG 23 59U1034 18U1034 7.6U1034 0.9U104
Magainin 1 DMPC 86 565U1034 8.0U1034 1.3U1034 0.9U104
DMPG 333 58U1034 11.7U1034 0.7U1034 91U104
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ported for melittin and magainin [25^27]. The trun-
cated melittin analogue, 21Q, exhibited lower bind-
ing a⁄nity than melittin for both lipids. In addition,
21Q had almost similar binding a⁄nity for the zwit-
terionic and negatively charged phospholipid surfa-
ces. Analysis of the sensorgrams using the parallel
reactions model yielded similar results (Table 3) to
the two-state reaction model in terms of the relative
binding a⁄nity of each peptide for both lipids.
3.2. Circular dichroism study
CD measurements were also performed to analyse
the conformation of the peptides in phosphate bu¡er
and in the presence of di¡erently surface charged
liposomes. Fig. 7 shows the CD spectra obtained
for magainin 1, melittin and the truncated analogue
of melittin (21Q) in phosphate bu¡er and in DMPC
and DMPG liposome solutions. The % helix values
were determined from [a]222 [16] and are listed in
Table 4. None of the peptides showed any secondary
structure in phosphate bu¡er nor did magainin 1 in
the presence of zwitterionic DMPC liposomes. In
contrast, melittin and its analogue, 21Q, adopted
K-helical conformation in the presence of DMPC
Table 3
Association (ka1, ka2) and dissociation (kd1, kd2) rate constants determined by numerical integration using the parallel reactions model,
and the a⁄nity (KA1, KA2) constants determined as ka1/kd1 and ka2/kd2, respectively. ka1, kd1 and KA1 are associated with the peptide-
lipid interaction, while ka2, kd2 and KA2 values are associated with the putative peptide-peptide interaction
Peptide Lipid type ka1 (1/Ms) kd1 (1/s) ka2 (1/Ms) kd2 (1/s) KA1 (1/M) KA2 (1/M)
Melittin DMPC 74 4.1U1034 1 001 125U1034 18U104 11U104
DMPG 3 079 3.7U1034 13 129 97U1034 838U104 135U104
21Q DMPC 26 2.5U1034 171 76U1034 10U104 2.3U104
DMPG 12 13U1034 67 81U1034 0.9U104 0.8U104
Magainin 1 DMPC 20 2.6U1034 919 681U1034 8.5U104 1.4U104
DMPG 687 1.8U1034 2 251 206U1034 380U104 11U104
Fig. 7. CD spectra of (A) melittin, (B) magainin 1 and (C) 21Q
in 20 mM phosphate bu¡er pH 6.8 (1) and in the presence of
DMPC (2) or DMPG (3) liposomes. The peptide concentration
is 20 WM, the peptide:lipid ratio is 1:100.
Table 4
% K-helicity of peptides in phosphate bu¡er (pH 6.8) and in
the presence of DMPC and DMPG liposomes at 25‡C
% K-helixa
Melittin 21Q Magainin 1
Bu¡er 0 0 0
DMPC 26 18 0
DMPG 58 18 57
a% K-helicity determined according to [15].
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liposomes and the helical content was calculated to
be 26% and 18%, respectively. All of the peptides
adopted K-helical conformation in anionic DMPG
liposome solution with a helical content of 57%,
58% and 18% found for magainin 1, melittin and
21Q, respectively.
4. Discussion
SPR analysis is now widely used to study anti-
body-antigen, protein-protein, DNA-protein, DNA-
DNA, receptor-ligand interactions [17,28^32]. More
recently, SPR has also been applied to the study of
biomembrane-based systems [14,33^37]. The present
study was undertaken with the aim of applying SPR
analysis to study the direct binding of peptides to
phospholipid membranes and to derive information
regarding the membrane selectivity and structure-
function relationship of antimicrobial peptides
through the binding a⁄nity data. Since very few
studies have been conducted in which SPR has
been used to examine peptide-membrane interactions
[38], no complete kinetic analysis or experimental
design has been investigated for such interactions.
The antimicrobial peptides magainin 1, melittin
and a C-terminally truncated analogue of melittin
(21Q) were used in this study. Magainin 1 is a 23
amino acid long amphipathic peptide that has been
isolated from the skin of the African clawed frog
Xenopus laevis. It possesses high antimicrobial, fun-
gicidal and virucidal activity and kills bacteria by
permeabilising its cell membrane [1,7]. Melittin is a
26 amino acid long amphipathic peptide that has
been isolated from the European honey bee (Apis
mellifera) venom. It has a moderate antibacterial
and antifungal activity and is highly haemolytic
[3,39]. The C-terminally truncated melittin analogue,
21Q, has the same sequence as melittin but residues
21^25 are omitted from the C-terminus. 21Q pos-
sesses lower antibacterial and haemolytic activity
than melittin [40]. Di¡erent hypotheses have been
proposed to explain the cytolytic activity of these
peptides. Fig. 8 shows two di¡erent models of pore
formation for melittin and magainin. Both peptides
are unstructured in aqueous solutions and form an
amphipathic K-helical conformation upon contact
with lipids. In the case of melittin, the evidence sug-
gests that the peptide inserts into the hydrocarbon
region of the target cell membrane and forms trans-
membrane pores by the assembly of several mono-
mers via a barrel-stave mechanism. The exterior of
the formed peptide ring contacts with the hydrocar-
bon region of the bilayer [5,41^43]. In the case of
magainin, the peptides align parallel to the outer
membrane surface disturbing the membrane struc-
ture. At high peptide concentration, the peptide in-
serts into the membrane and creates a toroidal pore.
During the whole process, the peptides remain in
contact with the head group region of the lipid bi-
layer. Upon disintegration of the toroidal pore, pep-
tides can translocate into the inner lea£et of the
membrane [42,44^46]. Although di¡erent pore for-
mation processes are proposed in these models, the
formation of an amphipathic helical structure is a
common feature for both peptides during the inter-
action with membrane surfaces. However, informa-
tion on the physicochemical properties of antimicro-
bial peptides, which give rise to the di¡erential
binding of various peptides to di¡erent lipids, is
not yet well understood. In the present study di¡er-
ently surface charged HBM systems were used to
investigate the interactive properties of antimicrobial
peptides during the initial binding and partial inser-
tion into a membrane.
To perform the membrane binding study, the
HBM system was prepared by adsorption of small
unilamellar vesicles onto the surface of an HPA sen-
sor chip that resembles the surface of a cellular mem-
Fig. 8. Schematic representation of the mechanism of pore for-
mation for (A) melittin and (B) magainin. See text for details.
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brane. Bu¡ered solution of each peptide was then
applied over the lipid surface and the resultant sen-
sorgrams were analysed by linearisation and numer-
ical integration to perform kinetic analysis. The re-
sults of the present study demonstrated that the
antimicrobial peptide-lipid interaction possesses com-
plicated kinetics, which re£ects a complex multistate
binding mechanism. The linearisation analysis and
the numerical integration analysis using the Lang-
muir binding model (data not shown) indicated
that this model is not applicable to the analysis of
the complex peptide-lipid interactions since it is
based on a simple bimolecular mechanism. However,
both the two-state reaction and parallel reactions
model gave signi¢cantly improved ¢t to the data,
suggesting that there are likely to be at least two
steps involved in the interaction between the peptide
and HBM system. In the case of the two-state reac-
tion model, the peptides may ¢rst bind to the lipid
head groups and then insert further into the hydro-
carbon region of the membrane. However, the pep-
tide may not be able to fully insert into the hybrid
bilayer due to the covalent attachment of the alkane-
thiol chains to the gold surface. The parallel reac-
tions model assumes two simple bimolecular interac-
tions running parallel with di¡erent rate constants
giving a complex bimolecular interaction. One possi-
ble molecular mechanism may involve a peptide-lipid
interaction when the peptides initially bind to the
HBM and then partially insert into the hybrid bi-
layer which may lead to limited disruption of the
adsorbed phospholipid layer. The other possible mo-
lecular mechanism may involve a peptide-peptide in-
teraction when the peptides bind to the already
bound peptides. While it is possible that the interac-
tions between antimicrobial peptides and membranes
are even more complex than can be described by
these two models, they provide a more appropriate
kinetic analysis of the interactions than the 1:1 bind-
ing model.
The biosensor binding data were also correlated
with the conformation of each peptide in the pres-
ence of either zwitterionic DMPC or anionic DMPG
liposomes determined by CD. The biosensor data
showed that melittin bound more strongly to zwitter-
ionic DMPC than magainin 1, and CD showed that
melittin adopted K-helical conformation in the pres-
ence of DMPC liposomes but magainin 1 had no
secondary structure. The biosensor data also showed
that both melittin and magainin 1 exhibited much
higher binding a⁄nity for the anionic DMPG than
for DMPC and CD indicated that the helical content
of both peptides was considerably higher in the pres-
ence of DMPG liposomes. This higher helical con-
tent directly correlated with higher lipid binding af-
¢nity, which demonstrates that the formation of an
K-helical structure is an important requirement in the
binding process, presumably due to the amphipathic
nature of each peptide helix.
The role of the C-terminal positive residues of me-
littin was also studied using the C-terminally trun-
cated analogue (21Q) of melittin. The biosensor and
CD results clearly demonstrated that the di¡erences
in the structure of melittin and 21Q in£uenced their
lipid binding properties. 21Q had a considerably
slower initial association with both lipids than melit-
tin. CD showed that both peptides adopted K-helical
conformation in the presence of zwitterionic DMPC
and anionic DMPG liposomes but the helical content
of 21Q remained at a similar lower level in both lipid
environments. Overall, melittin adopted a consider-
ably higher degree of helical structure in the presence
of DMPG and bound stronger to both lipids than
21Q, showing that the positively charged C-terminal
residues of melittin contribute signi¢cantly to the
binding a⁄nity of melittin for DMPG. Thus, the
absence of positively charged C-terminal residues in
21Q resulted in a loss of binding speci¢city with sim-
ilar low binding a⁄nities observed for this peptide
with DMPC and DMPG. Comparison of the results
of melittin and 21Q thus indicates that the positive
tail of melittin allows it to bind more rapidly and
more strongly to the anionic lipids by electrostatic
interactions, thereby enhancing the subsequent hy-
drophobic binding. These results also clearly demon-
strate the role of electrostatic interactions in the ini-
tial orientation and binding of these peptides to
membrane. In particular, these results suggest that
electrostatic interactions may correspond to the ini-
tial rapid phase since 21Q exhibited a slower associ-
ation phase than melittin. The subsequent insertion/
peptide aggregation step may then correspond to the
slower second phase of binding.
The biosensor and CD results presented here can
also be correlated with the biological activity and
binding properties of these peptides observed in pre-
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vious studies. For example, it has been shown that
magainin has a low haemolytic activity with biomem-
branes containing zwitterionic DMPC in the outer
lea£et of the cellular membrane [47]. Other studies
have also suggested that the membrane selectivity
and the cytolytic and antimicrobial activity of mag-
ainin are related to the hydrophobicity of magainin
which is too low to e¡ectively associate with mem-
branes which are mainly composed of zwitterionic
phospholipids [7,22,48]. The present study also dem-
onstrated a weak a⁄nity of magainin 1 for zwitter-
ionic DMPC, which predominates in eucaryotic
membranes, and which may be partly responsible
for its low haemolytic activity. The very strong bind-
ing of magainin 1 to the negatively charged lipids
and the high helical content in anionic DMPG lipo-
some solution agree with the fact that magainin pref-
erentially acts on bacterial cells containing large
amounts of anionic phospholipids via electrostatic
interactions [1,22].
The experimental data presented here also showed
that melittin interacts strongly with both zwitterionic
and anionic lipids, which correlates with the fact that
melittin binds and lyses both bacterial and eucaryotic
cells [7,22]. Previous studies also found that melittin
is 5 times more haemolytic than its C-terminally
truncated analogue, 21Q [40]. Schroeder and co-
workers also showed that the C-terminal charges of
melittin are vital for haemolytic activity, since the
deletion of the charged residues (KRKRQQ) from
the C-terminus of melittin resulted in the loss of hae-
molytic activity [6]. The low haemolytic activity of
the C-terminally truncated melittin analogue [6,40]
thus suggests that the positive charges are important
for membrane recognition providing the initial elec-
trostatic binding. The biosensor results in this study
also suggest that the positive charges actually in-
crease the lipid binding a⁄nity of melittin, thereby
enhancing its haemolytic activity.
5. Conclusions
We found that biosensor technology represents a
new and useful experimental procedure to rapidly
determine the relative a⁄nity of bioactive peptides
for phospholipid surfaces. In particular, this tech-
nique can provide information on the role of electro-
static interactions in membrane binding and provide
an insight into the structure-biological activity rela-
tionship. The results demonstrated that di¡erences in
antimicrobial peptide-lipid membrane a⁄nity and in
the kinetics of lipid binding of these peptides can be
easily determined, which correlate with their experi-
mentally observed rate of haemolytic activity, anti-
microbial activity and membrane selectivity.
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